Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.

Donadini MP, Ageno W, Douketis JD.

Drugs. 2012 Oct 22;72(15):1965-75. doi: 10.2165/11641160-000000000-00000. Review.

PMID:
23039318
2.

Reversal of antithrombotic agents.

Bauer KA.

Am J Hematol. 2012 May;87 Suppl 1:S119-26. doi: 10.1002/ajh.23165. Epub 2012 Mar 28. Review.

3.

Approaches to diagnosing and managing anticoagulant-related bleeding.

Goy J, Crowther M.

Semin Thromb Hemost. 2012 Oct;38(7):702-10. doi: 10.1055/s-0032-1326788. Epub 2012 Oct 3. Review.

PMID:
23034830
4.

Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents.

Siegal DM.

J Thromb Thrombolysis. 2015 Apr;39(3):395-402. doi: 10.1007/s11239-015-1167-9. Review.

PMID:
25586208
5.

[Direct oral anticoagulant associated bleeding].

Godier A, Martin AC, Rosencher N, Susen S.

J Mal Vasc. 2016 Jul;41(4):272-8. doi: 10.1016/j.jmv.2016.05.008. Epub 2016 Jun 11. Review. French.

PMID:
27297642
6.

[Bleeding complications of anticoagulant therapy].

Gumulec J, Kessler P, Procházka V, Brejcha M, Penka M, Zänger M, Machytka E, Klement P.

Vnitr Lek. 2009 Mar;55(3):277-89. Review. Czech.

PMID:
19378860
7.

The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism.

Haverkamp D, Hutten BA, Büller HR, Gallus AS, Lensing AW, Prins MH.

J Thromb Haemost. 2003 Jan;1(1):69-73.

8.

How we treat bleeding associated with direct oral anticoagulants.

Marano G, Vaglio S, Pupella S, Liumbruno GM, Franchini M.

Blood Transfus. 2016 Sep;14(5):465-73. doi: 10.2450/2016.0180-15. Epub 2016 Jan 19. Review.

9.

Specific antidotes in development for reversal of novel anticoagulants: a review.

Gomez-Outes A, Suarez-Gea ML, Lecumberri R, Terleira-Fernandez AI, Vargas-Castrillon E.

Recent Pat Cardiovasc Drug Discov. 2014;9(1):2-10. Review.

PMID:
25494843
10.

Direct oral anticoagulants: new drugs and new concepts.

Levy JH, Spyropoulos AC, Samama CM, Douketis J.

JACC Cardiovasc Interv. 2014 Dec;7(12):1333-51. doi: 10.1016/j.jcin.2014.06.014. Review.

11.

Bleeding and antidotes in new oral anticoagulants.

Majeed A, Schulman S.

Best Pract Res Clin Haematol. 2013 Jun;26(2):191-202. doi: 10.1016/j.beha.2013.07.001. Epub 2013 Jul 21. Review.

PMID:
23953907
12.

Emergency management of bleeding associated with old and new oral anticoagulants.

Peacock WF, Gearhart MM, Mills RM.

Clin Cardiol. 2012 Dec;35(12):730-7. doi: 10.1002/clc.22037. Epub 2012 Jul 18. Review.

13.

Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.

Linkins LA, Choi PT, Douketis JD.

Ann Intern Med. 2003 Dec 2;139(11):893-900.

PMID:
14644891
14.

Reversal of novel oral anticoagulants in patients with major bleeding.

Siegal DM, Cuker A.

J Thromb Thrombolysis. 2013 Apr;35(3):391-8. doi: 10.1007/s11239-013-0885-0. Review.

PMID:
23389753
15.

Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.

Beyer-Westendorf J, Ageno W.

Thromb Haemost. 2015 Feb;113(2):231-46. doi: 10.1160/TH14-06-0484. Epub 2014 Oct 16. Review.

PMID:
25319150
16.

Developing a management plan for oral anticoagulant reversal.

Dager WE.

Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S21-31. doi: 10.2146/ajhp130042. Erratum in: Am J Health Syst Pharm. 2013 Jul 1;70(13):1098. Dosage error in article text.

PMID:
23640529
17.

Reversal of Dabigatran with Idarucizumab.

Sodha NR, Sellke FW.

Expert Rev Cardiovasc Ther. 2016 Aug;14(8):889-93. doi: 10.1080/14779072.2016.1203253. Epub 2016 Jun 30.

PMID:
27362456
18.

Overview of direct oral anticoagulant therapy reversal.

Gulseth MP.

Am J Health Syst Pharm. 2016 May 15;73(10 Suppl 2):S5-S13. doi: 10.2146/ajhp150966. Review.

PMID:
27147458
19.

Monitoring and reversal strategies for new oral anticoagulants.

Vanden Daelen S, Peetermans M, Vanassche T, Verhamme P, Vandermeulen E.

Expert Rev Cardiovasc Ther. 2015 Jan;13(1):95-103. doi: 10.1586/14779072.2015.987126. Epub 2014 Nov 28. Review.

PMID:
25431993
20.

[Therapeutic approach to the bleeding in association with "old" and "new" anticoagulants].

Dulíček P.

Vnitr Lek. 2012 Jul-Aug;58(7-8):559-63. Review. Czech.

PMID:
23067175

Supplemental Content

Support Center